InterCure (INCR) Short Interest Ratio & Short Volume → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free INCR Stock Alerts $2.66 +0.02 (+0.76%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media InterCure Short Interest DataCurrent Short Volume56,200 sharesPrevious Short Volume90,200 sharesChange Vs. Previous Month-37.69%Dollar Volume Sold Short$137,690.00Short Interest Ratio / Days to Cover0.6Last Record DateApril 15, 2024Outstanding Shares45,570,000 sharesFloat Size27,370,000 sharesShort Percent of Float0.21%Today's Trading Volume11,909 sharesAverage Trading Volume53,848 sharesToday's Volume Vs. Average22% Short Selling InterCure ? Sign up to receive the latest short interest report for InterCure and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINCR Short Interest Over TimeINCR Days to Cover Over TimeINCR Percentage of Float Shorted Over Time Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 InterCure Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202456,200 shares $137,690.00 -37.7%0.2%0.6 $2.45 3/31/202490,200 shares $244,442.00 -14.6%0.3%1 $2.71 3/15/2024105,600 shares $195,360.00 -23.7%0.4%1.3 $1.85 2/29/2024138,400 shares $271,264.00 +3.6%0.5%1.9 $1.96 2/15/2024133,600 shares $233,800.00 -31.7%0.5%1.9 $1.75 1/31/2024195,700 shares $230,926.00 -9.6%0.7%2.6 $1.18 Get the Latest News and Ratings for INCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for InterCure and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024216,400 shares $318,108.00 +7.3%0.8%4.3 $1.47 12/31/2023201,600 shares $260,023.68 -2.0%0.7%4.4 $1.29 12/15/2023205,600 shares $248,776.00 -4.6%0.8%4.7 $1.21 11/30/2023215,600 shares $263,032.00 +317.8%0.8%5 $1.22 11/15/202351,600 shares $65,532.00 +11.5%0.2%1.1 $1.27 10/31/202346,300 shares $46,763.00 +13.2%0.2%1.1 $1.01 10/15/202340,900 shares $53,579.00 +18.9%0.2%1 $1.31 9/30/202334,400 shares $54,008.00 -42.6%0.1%0.8 $1.57 9/15/202359,900 shares $101,231.00 +71.6%0.2%1.2 $1.69 8/31/202334,900 shares $56,189.00 +156.6%0.1%0.8 $1.61 8/15/202313,600 shares $20,808.00 -28.0%0.1%0.3 $1.53 7/31/202318,900 shares $30,051.00 -62.2%0.1%0.4 $1.59 7/15/202350,000 shares $82,000.00 +36.6%0.2%1.1 $1.64 6/30/202336,600 shares $62,220.00 -11.6%0.1%0.8 $1.70 6/15/202341,400 shares $88,182.00 +18.3%0.2%0.9 $2.13 5/31/202335,000 shares $67,900.00 -40.2%0.1%0.6 $1.94 5/15/202358,500 shares $150,930.00 +28.9%0.2%0.9 $2.58 4/30/202345,400 shares $105,782.00 -15.9%0.2%0.7 $2.33 4/15/202354,000 shares $120,960.00 -16.4%0.2%0.8 $2.24 3/31/202364,600 shares $131,784.00 -26.5%0.2%1 $2.04 3/15/202387,900 shares $169,647.00 +13.3%0.3%1.5 $1.93 2/28/202377,600 shares $191,672.00 +7.3%0.3%1.9 $2.47 2/15/202372,300 shares $245,820.00 -39.9%0.3%1.9 $3.40 1/31/2023120,200 shares $442,336.00 +71.2%0.4%3.9 $3.68 1/15/202370,200 shares $267,462.00 -12.6%0.3%2.7 $3.81 12/30/202280,300 shares $264,990.00 -13.4%0.3%3.5 $3.30 12/15/202292,700 shares $396,756.00 +1.0%0.3%3 $4.28 11/30/202291,800 shares $455,328.00 +71.6%0.3%2.4 $4.96 11/15/202253,500 shares $281,410.00 -40.3%0.2%1.2 $5.26 10/31/202289,600 shares $431,872.00 -5.5%0.3%1.3 $4.82 10/15/202294,800 shares $430,392.00 +5.1%0.4%1.4 $4.54 9/30/202290,200 shares $405,900.00 +58.5%0.3%1.3 $4.50 9/15/202256,900 shares $249,791.00 -31.5%0.2%0.9 $4.39 8/31/202283,000 shares $429,110.00 +14.6%0.3%1.5 $5.17Exposed: 10 CENT Crypto to Explode April 20th? (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 INCR Short Interest - Frequently Asked Questions What is InterCure's current short interest? Short interest is the volume of InterCure shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 56,200 shares of INCR short. 0.21% of InterCure's shares are currently sold short. Learn More on InterCure's current short interest. What is a good short interest ratio for InterCure? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INCR shares currently have a short interest ratio of 1.0. Learn More on InterCure's short interest ratio. Which institutional investors are shorting InterCure? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of InterCure: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for InterCure? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.21% of InterCure's floating shares are currently sold short. Is InterCure's short interest increasing or decreasing? InterCure saw a decrease in short interest in April. As of April 15th, there was short interest totaling 56,200 shares, a decrease of 37.7% from the previous total of 90,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is InterCure's float size? InterCure currently has issued a total of 45,570,000 shares. Some of InterCure's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. InterCure currently has a public float of 27,370,000 shares. How does InterCure's short interest compare to its competitors? 0.21% of InterCure's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to InterCure: PDS Biotechnology Co. (19.47%), Relmada Therapeutics, Inc. (5.67%), Coya Therapeutics, Inc. (1.47%), Nuvectis Pharma, Inc. (11.84%), Adagene Inc. (0.04%), GlycoMimetics, Inc. (4.67%), Societal CDMO, Inc. (0.00%), Emergent BioSolutions Inc. (11.76%), Rezolute, Inc. (0.60%), Seres Therapeutics, Inc. (11.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short InterCure stock? Short selling INCR is an investing strategy that aims to generate trading profit from InterCure as its price is falling. INCR shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against InterCure? A short squeeze for InterCure occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INCR, which in turn drives the price of the stock up even further. How often is InterCure's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INCR, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: PDSB Short Interest RLMD Short Interest COYA Short Interest NVCT Short Interest ADAG Short Interest GLYC Short Interest SCTL Short Interest EBS Short Interest RZLT Short Interest MCRB Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INCR) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press